Erythropoietin prevents the increase in blood–brain barrier permeability during pentylentetrazol induced seizures
- 25 April 2006
- journal article
- Published by Elsevier in Life Sciences
- Vol. 78 (22) , 2571-2576
- https://doi.org/10.1016/j.lfs.2005.10.027
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Erythropoietin protects the in vitro blood–brain barrier against VEGF‐induced permeabilityEuropean Journal of Neuroscience, 2003
- Pharmacological evidence for a role of γ-aminobutyric acid A receptor mechanism in modulating nitric oxide synthase activity in rat brainNeurochemistry International, 2001
- The Biology of Erythropoietin in the Central Nervous System and Its Neurotrophic and Neuroprotective PotentialNeonatology, 2001
- Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activityKidney International, 2000
- CHRONIC NICOTINE PRETREATMENT PROTECTS THE BLOOD–BRAIN BARRIER AGAINST NICOTINE-INDUCED SEIZURES IN THE RATPharmacological Research, 1999
- Morphological and functional characterization of an in vitro blood–brain barrier modelBrain Research, 1997
- Detection of erythropoietin in human liquor: Intrinsic erythropoietin production in the brainKidney International, 1997
- Nitric oxide inhibition of the depolarization-evoked glutamate release from synaptosomes of rat cerebellumNeuroscience Letters, 1995
- Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizure threshold in a cortical stimulation model in ratsEuropean Journal of Pharmacology, 1995
- Effect of Recombinant Human Erythropoietin on Anterior Pituitary Function in Patients on Chronic HemodialysisHormone Research, 1991